| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.3 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |